Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023;48(1):66-78.
doi: 10.1159/000528556. Epub 2022 Dec 8.

Therapeutic Plasmapheresis: A Revision of Literature

Claudia Altobelli  1 , Pietro Anastasio  2 , Alessandro Cerrone  2 , Elisabetta Signoriello  3 , Giacomo Lus  3 , Corrado Pluvio  1 , Alessandra F Perna  2 , Giovambattista Capasso  2 , Mariadelina Simeoni  2 , Giovanna Capolongo  4
Affiliations
Review

Therapeutic Plasmapheresis: A Revision of Literature

Claudia Altobelli et al. Kidney Blood Press Res. 2023.

Abstract

Background: Therapeutic plasmapheresis (TP) is an extracorporeal therapy that allows the removal of pathogens from plasma. The role of TP in immuno-mediated diseases and toxic conditions has been of interest for decades.

Summary: We reviewed the recent literature on the application and the optimal choice of TP technique ranging from plasma exchange, double filtration plasmapheresis, rheopheresis, immunoadsorptions, plasma adsorption perfusion and lipidoapheresis. In addition, we report our experience in the application of TP for various diseases ranging in different medical specialties, following the American Society for Apheresis (ASFA) recommendations.

Key messages: Overall patients receiving TP showed an improvement in clinical and laboratory parameters. Our review and single-center experience suggest a benefit of the application of TP in multiple clinical disciplines.

Keywords: Autoimmune disease; Double filtration plasmapheresis; Literature review; Plasma purification techniques; Therapeutic plasmapheresis.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

References

    1. Busnach G, Passalacqua S. Gruppo di Studio Aferesi Terapeutica della Società Italiana di Nefrologia. Linee Guida per l'aferesi terapeutica in Nefrologia. G It Nefrol. 2000;17((4)):433–439.
    1. Ipe TS, Marques MB. Vascular access for therapeutic plasma exchange. Transfusion. 2018 Feb;58((Suppl 1)):580–589. - PubMed
    1. Rock G. In Plasmapheresis: therapeutic application and new techniques. New York: Raven Press; 1983. Centrifugal apheresis techniques; pp. p. 75–79.
    1. Baldini R. Le aferesi selettive. Tecnologie. Available from: https://docplayer.it/14756352-Le-aferesi-selettive-tecnologia.html.
    1. McLeod BC. An approach to evidence-based therapeutic apheresis. J Clin Apher. 2002;17((3)):124–132. - PubMed